A total of 100 Mongolian volunteers (men: 39, women: 61), aged 18–25 years, were recruited from the Health Sciences University of Mongolia (Ulaanbaatar city, Mongolia). Similarly, 115 volunteers (men: ...
Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension. NEW ORLEANS — ...
Drugs currently marketed for pulmonary arterial hypertension have been able to extend the lives of patients but have shown limitations in their ability to prevent or reverse the disease. A novel ...
WASHINGTON -- The novel investigational therapy seralutinib effectively reduced pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH) on standard background ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...
An ongoing multicenter study in Japan will evaluate reductions in pulmonary vascular resistance 8 months after initiating the combination therapy in pulmonary arterial hypertension. An ongoing study ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among adults with pulmonary arterial hypertension, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback